Found 57 matching trials
The Hemophilia Inhibitor Prevention Trial
PHASE3This is a multi-center randomized phase III clinical trial, the Inhibitor P...
Location
University of Arkansas Medical Sciences Childrens Hospital
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
N/AHemophilia A (HA) is a genetic bleeding disorder resulting from a deficienc...
Location
Arkansas Children's Hospital
The Hemophilia Inhibitor Eradication Trial
PHASE3This is a multi-center randomized phase III clinical trial, the Inhibitor E...
Location
Hemophilia Center of Western PA
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
EARLY_PHASE1This trial will enroll patients with severe hemophilia A. Experiments will ...
Location
Tulane University Lakeside Hospital and Clinics
Emicizumab in Acquired Hemophilia A
PHASE2This study is an international, multicenter, open-label, single arm, prospe...
Location
Medizinische UniversitÀt Wien, HÀmatologie/HÀmostaseologie
Treatment of Hemophilia A Patients With FVIII Inhibitors
N/AThis is a non-interventional, multicenter, observational, international stu...
Location
Arthur M. Blank Hospital
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
N/AThe goal of this observational study is to learn about the changes of antib...
Location
University Hospital Frankfurt, Goethe University
A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab
PHASE4Hemophilia A is a severe, life-long, genetic bleeding disorder characterize...
Status
Active Not Recruiting
Location
Childrens Hospital Los Angeles
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
N/AThe investigators propose to study longitudinal joint and bone density chan...
Location
Orthopedic Hemophilia Treatment Center
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunteers
PHASE1This single-center, open-label study will evaluate the pharmacokinetics, sa...
Location
Peking University Third Hospital